Monitor for additional Form 144 or Form 4 filings from Kapadia and other insiders. The sustained selling pattern by a former officer over the past six weeks is a negative signal. Watch next earnings for any fundamental deterioration that might explain the insider reduction.
How the stock moved after the report
BEARISH VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Jun 25 $34.13entry
- T+1 · 5mo ago +3.93%α +4.65% · $35.47
- T+5 · 5mo ago +5.48%α +3.92% · $36.00
- T+20 · 4mo ago +4.89%α +4.36% · $35.80
- T+60 · due 8w ago Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Former officer Sandip Kapadia filed a Form 144 notice of intent to sell 4,406 shares of Harmony Biosciences common stock, valued at approximately $154,302, via Morgan Stanley. The shares were acquired through option exercises under a registered plan. Kapadia has sold a total of 82,606 shares since early May 2026, representing a meaningful reduction of his position.
Key Facts
- Former officer Sandip Kapadia filed Form 144 on 2026-06-24 to sell 4,406 shares (~$154,302).
- Shares were acquired via exercise of options under a registered plan on the same date.
- Kapadia has sold 82,606 shares total since May 8, 2026, including 27,960 on 6/9, 2,101 on 6/5, 7,064 on 6/4, and 45,481 on 5/8.
- The filing does not disclose Kapadia's remaining holdings, but the cumulative sales since May 8 represent a significant insider reduction.
- The stock trades on Nasdaq under ticker HRMY with a $2.0B market cap.
Financial Impact
Proposed sale of 4,406 shares at ~$154,302; cumulative insider sales of 82,606 shares since May 8, 2026.
Risk Factors
- Insider selling may indicate lack of confidence in near-term prospects or upcoming negative catalyst.
- Further insider sales could pressure the stock price.
- The selling is by a former officer, which may be part of routine post-employment diversification, but the volume and timing are notable.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006445 |
| Document: 0001950047-26-006445-index.html | 0001950047-26-006445 |
| Document: 0001950047-26-006445.txt | 0001950047-26-006445 |
Track record
20 reports on HRMY
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 3/10 Entry $33.21 Now $32.96 −0.75% settles Dec 15
- Nov 4, 202612d ago 8-K Bearish 5/10 No price data
- Nov 4, 202612d ago Press Release Bearish 5/10 Entry $34.42 Now $32.96 +4.23% settles Dec 3
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $37.02 Now $32.96 −10.97% settles Dec 2
- Oct 30, 202617d ago 8-K/A Neutral 3/10 Entry $37.91 Now $32.96 −13.06% settles Dec 1
- Oct 27, 202620d ago SC 13G/A Neutral 2/10 Entry $38.50 Now $32.96 −14.39% settles Nov 25
- Oct 13, 20264w ago 8-K Neutral 3/10 Entry $37.03 to $33.55 Now $32.96 −10.99% ▼ −9.40% −5.79% vs SPY
- Oct 1, 20266w ago Press Release Neutral 3/10 Entry $39.57 to $38.59 Now $32.96 −16.70% ▼ −2.48% −3.18% vs SPY
- Aug 4, 202614w ago 8-K Bullish 7/10 No price data
- Aug 4, 202614w ago Press Release Bullish 6/10 Entry $38.78 Now $32.96 −15.01% No price data
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers